| (210) | Number of the EPO application | 17767462 |
| (220) | Filing date of the EPO application | 2017.03.15 |
| (80) | EPO patent specification publication (B) | EPB nr. 11/2023, 2023.03.15 |
| (110) | EPO patent number | 3429591 |
| (11) | Number of the document | MD 3429591 T2 |
| (21) | Number of the application | e 2019 0122 |
| (71) | Name(s) of applicant(s), code of the country | Kura Oncology, Inc., US;
The Regents of The University of Michigan, US; |
| (72) | Name(s) of inventor(s), code of the country | WU Tao, US;
LI Liansheng, US;
WANG Yi, US;
REN Pingda, US;
GREMBECKA Jolanta, US;
CIERPICKI Tomasz, US;
KLOSSOWSKI Szymon, US;
POLLOCK Jonathan, US;
BORKIN Dmitry, US; |
| (73) | Name(s) of owner(s), code of the country | Kura Oncology, Inc., US;
The Regents of The University of Michigan, US; |
| (54) | Title of the invention | Substituted thieno[2,3-d]pyrimidine derivatives as inhibitors of menin-MLL and methods of use |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/535 (2006.01.01); C07D 495/04 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.08.31 |
| (30) | Priority | 201662309372 P, 2016.03.16, US; 201662334369 P, 2016.05.10, US; 201662431389 P, 2016.12.07, US; 201762446640 P, 2017.01.16, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2017/022564, 2017.03.15 |
| (87) | International publication | WO 2017/161028, 2017.09.21 |